• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌和胃癌的分期

Staging in Esophageal and Gastric Cancers.

作者信息

Hayes Thomas, Smyth Elizabeth, Riddell Angela, Allum William

机构信息

Department of Gastrointestinal Oncology, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK; Department of Radiology, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK; Department of Surgery, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK.

Department of Gastrointestinal Oncology, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK; Department of Radiology, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK; Department of Surgery, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK.

出版信息

Hematol Oncol Clin North Am. 2017 Jun;31(3):427-440. doi: 10.1016/j.hoc.2017.02.002.

DOI:10.1016/j.hoc.2017.02.002
PMID:28501085
Abstract

Gastric and esophageal tumors have a poor prognosis; approximately 15% of patients are alive at 10 years following diagnosis. Surgical resection plus adjunctive chemotherapy or chemoradiotherapy is curative in approximately 50% of patients with operable disease, but is also associated with significant morbidity. Therefore, accurate preoperative staging is required to spare patients unnecessary toxicity and futile surgery. This review evaluates the sensitivity and specificities of the modalities used to stage patients with gastroesophageal cancer. Staging techniques reviewed include CT, PET, MRI, EUS, and laparoscopy. The article concludes with suggestions on appropriate staging tools according to site and stage of disease.

摘要

胃癌和食管癌预后较差;诊断后10年约15%的患者存活。手术切除加辅助化疗或放化疗可治愈约50%可手术治疗的患者,但也会带来显著的发病率。因此,需要准确的术前分期,以使患者避免不必要的毒性和无效的手术。本综述评估了用于对胃食管癌患者进行分期的各种方法的敏感性和特异性。所综述的分期技术包括CT、PET、MRI、EUS和腹腔镜检查。文章最后根据疾病部位和分期对合适的分期工具提出了建议。

相似文献

1
Staging in Esophageal and Gastric Cancers.食管癌和胃癌的分期
Hematol Oncol Clin North Am. 2017 Jun;31(3):427-440. doi: 10.1016/j.hoc.2017.02.002.
2
A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.前瞻性评估 2-脱氧-2-[(18)F]氟-D-葡萄糖正电子发射断层扫描和计算机断层扫描在局部进展期胃癌分期中的应用。
Cancer. 2012 Nov 15;118(22):5481-8. doi: 10.1002/cncr.27550. Epub 2012 May 1.
3
Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.使用内镜超声和腹腔镜超声对上消化道癌患者进行治疗前评估。
Dan Med J. 2012 Dec;59(12):B4568.
4
Computed tomography or endoscopic ultrasonography in preoperative staging of gastric and esophageal tumors.计算机断层扫描或内镜超声检查在胃和食管肿瘤术前分期中的应用
Surgery. 1994 Oct;116(4):696-701; discussion 701-2.
5
FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(FDG-PET-CT)可提高肠型而非弥漫型食管胃腺癌患者术前淋巴结分期的特异性。
Eur J Surg Oncol. 2017 Jan;43(1):196-202. doi: 10.1016/j.ejso.2016.08.020. Epub 2016 Sep 7.
6
The utility of FDG-PET in the preoperative staging of esophageal cancer.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在食管癌术前分期中的应用。
Dis Esophagus. 2008;21(5):389-94. doi: 10.1111/j.1442-2050.2007.00802.x.
7
The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.超声内镜(EUS)在联合CT和正电子发射断层扫描的多模态食管癌分期方案中的作用及临床价值。
Gastrointest Endosc. 2007 Mar;65(3):377-84. doi: 10.1016/j.gie.2006.12.015.
8
The Multidisciplinary Team Conference's Decision on M-Staging in Patients with Gastric- and Gastroesophageal Cancer is not Accurate without Staging Laparoscopy.多学科团队会议对胃癌和胃食管癌患者进行M分期的决定,如果没有分期腹腔镜检查则不准确。
Scand J Surg. 2016 Jun;105(2):104-8. doi: 10.1177/1457496915598760. Epub 2015 Aug 10.
9
Gastric cancer staging with radiologic imaging modalities and UICC staging system.胃癌的影像学分期及 UICC 分期系统。
Dig Surg. 2013;30(2):142-9. doi: 10.1159/000350881. Epub 2013 Jul 18.
10
Positron emission tomography in the staging of esophageal cancer.正电子发射断层扫描在食管癌分期中的应用
Rays. 2006 Jan-Mar;31(1):9-12.

引用本文的文献

1
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).《2024年韩国胃癌诊疗指南:基于证据的多学科方法(2022年指南更新)》
J Gastric Cancer. 2025 Jan;25(1):5-114. doi: 10.5230/jgc.2025.25.e11.
2
A deep learning-based system for mediastinum station localization in linear EUS (with video).一种基于深度学习的线性超声内镜纵隔部位定位系统(附视频)
Endosc Ultrasound. 2023 Sep-Oct;12(5):417-423. doi: 10.1097/eus.0000000000000011. Epub 2023 Oct 16.
3
A preoperative predictive tool to assess the need for staging laparoscopy in oesophagogastric cancer patients.
一种用于评估食管胃交界部癌患者进行分期腹腔镜检查必要性的术前预测工具。
Ann R Coll Surg Engl. 2024 Apr;106(4):369-376. doi: 10.1308/rcsann.2022.0140. Epub 2023 Aug 29.
4
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.《2022年韩国胃癌诊疗指南:基于证据的多学科方法》
J Gastric Cancer. 2023 Jan;23(1):3-106. doi: 10.5230/jgc.2023.23.e11.
5
The T stage of esophageal cancer can be effectively predicted by muscularis propria thickness and muscularis propria + mucosa thickness under ultrasonic gastroscopy.超声胃镜下固有肌层厚度及固有肌层+黏膜层厚度可有效预测食管癌 T 分期。
Thorac Cancer. 2023 Jan;14(2):127-134. doi: 10.1111/1759-7714.14722. Epub 2022 Nov 15.
6
Neoantigens and their clinical applications in human gastrointestinal cancers.新抗原及其在人类胃肠道癌症中的临床应用。
World J Surg Oncol. 2022 Sep 29;20(1):321. doi: 10.1186/s12957-022-02776-y.
7
Tc bone scintigraphy does not affect preoperative workup for patients with potentially resectable esophageal squamous cell carcinoma.锝骨扫描对可切除的食管鳞癌患者的术前检查没有影响。
Thorac Cancer. 2022 Aug;13(16):2371-2376. doi: 10.1111/1759-7714.14575. Epub 2022 Jul 10.
8
Demographic, endoscopic and histological profile of esophageal cancer at the Gastroenterology Department of Maputo Central Hospital from January 2016 to December 2018.莫桑比克马普托中央医院消化内科 2016 年 1 月至 2018 年 12 月食管癌的人口统计学、内镜和组织学特征。
Pan Afr Med J. 2022 Feb 4;41:100. doi: 10.11604/pamj.2022.41.100.30941. eCollection 2022.
9
Prolactin (PRL), placenta growth factor (PIGF) and nerve growth factor receptor (NGFR) as biomarkers for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma (ESCC).催乳素(PRL)、胎盘生长因子(PIGF)和神经生长因子受体(NGFR)作为食管鳞状细胞癌(ESCC)患者早期诊断和预后的生物标志物。
Transl Cancer Res. 2020 Feb;9(2):647-656. doi: 10.21037/tcr.2019.12.31.
10
Clinical application of thioredoxin reductase as a novel biomarker in liver cancer.硫氧还蛋白还原酶在肝癌中的新型生物标志物的临床应用。
Sci Rep. 2021 Mar 16;11(1):6069. doi: 10.1038/s41598-021-85688-3.